课题基金 / 基金详情

BU Clinical HIV/AIDS Research Training Program (BU-CHART

BU Clinical HIV/AIDS Research Training Program (BU-CHART
BU 临床艾滋病毒/艾滋病研究培训计划 (BU-CHART
批准号:
10633204
负责人:
Benjamin P. Linas
金额:
$48.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
未结题
起止时间:
2003-08-01 至 2026-07-31

项目摘要

项目成果

Benjamin P. Linas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The Boston University Clinical HIV/AIDS Research Training (BU-CHART) program prepares outstanding M.D and Ph.D. trainees for careers as scientific leaders in HIV/AIDS research, with a focus on research in disadvantaged and underserved populations. BU-CHART focuses its training plan on four high-priority HIV research fields that address the substantial challenges that remain to ending the HIV epidemic: 1) substance use and HIV - a syndemic of substance use disorders and HIV infection fuels HIV outbreaks in the U.S., Eastern Europe, and Asia. 2) Tuberculosis and HCV co-infection - comorbidities, including Tuberculosis and Hepatitis C Virus are leading causes of death among HIV-infected people; 3) HIV transmission and establishment of latency - HIV incidence remains stubbornly elevated, and early establishment of HIV latency remains a frustrating puzzle that limits progress to finding HIV cure; 4) HIV treatment and the accelerated aging process - we still seek safe and effective interventions to reduce the inappropriate immune activation that accompanies HIV infection and leads to end-organ disease. The training facilities include state-of-the-art research space at Boston University Schools of Medicine and Public Health and Boston Medical Center, the largest Safety-net hospital in New England. BU-CHART synergizes with existing training programs on campus, including the BU Clinical and Translational Science Institute (CTSI), the Providence-Boston Center for AIDS Research, and other T32- and R25-funded training programs on the BUMC campus. We pair our outstanding trainees with BU-CHART faculty mentors who are established investigators with NIH-funded research projects and experience mentoring. We provide a thoughtfully constructed training plan in scientific reasoning and experimental design, professional development, and the ethical conduct of human research. The result is a track record of training success. In the past 15 years, BU-CHART trained 26 MD and PhD post-doctoral fellows, of whom 20 (77%) remain in in academic positions focused on HIV research. Among the 7 trainees who completed the program in the current grant cycle, 6 now have academic research positions, 3 have already obtained career development awards, and 2 have career development awards currently under review.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0204020
发表时间: 2018
期刊: PloS one
影响因子: 3.7
作者: [Brennan AT, Jamieson L, Crowther NJ, Fox MP, George JA, Berry KM, Stokes A, Maskew M, Sanne I, Long L, Cassim N, Rosen S]
通讯作者: Rosen S
Sustained reduction in tuberculosis incidence following a community-based participatory intervention.
基于社区的参与性干预措施使结核病发病率持续下降。
DOI: 10.5588/pha.11.0023
发表时间: 2012
期刊: Public health action
影响因子: 1.4
作者: [O'Donnell,MR, Chamblee,S, vonReyn,CF, Marsh,BJ, Moreland,JD, Narita,M, Johnson,LS, HorsburghJr,CR]
通讯作者: HorsburghJr,CR
The role of tissue plasminogen activator use and systemic hypercoagulability in central line-associated bloodstream infections.
组织纤溶酶原激活剂的使用和全身高凝状态在中心导管相关血流感染中的作用。
DOI: 10.1016/j.ajic.2013.11.016
发表时间: 2014
期刊: American journal of infection control
影响因子: 4.9
作者: [Thakarar,Kinna, Collins,Matthew, Kwong,Lana, Sulis,Carol, Korn,Cathy, Bhadelia,Nahid]
通讯作者: Bhadelia,Nahid
Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.
改善南非广泛耐药结核病和艾滋病毒患者的早期结果。
DOI: --
发表时间: 2009
期刊: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
影响因子: --
作者: [O'Donnell,MaxR, Padayatchi,N, Master,I, Osburn,G, Horsburgh,CR]
通讯作者: Horsburgh,CR
17
    HEAL Data2Action Modeling and Economic Resource Center
    HEAL Data2Action Modeling and Economic Resource Center
    Researching Effective Strategies to Prevent Opioid Death (RESPOND)
    • 批准号:
      10804924
    • 项目类别:
    • 资助金额:
      $89.58万
    • 财政年份:
      2018
    • 负责人:
      Benjamin P. Linas
    • 依托单位:
    Researching Effective Strategies to Prevent Opioid Death (RESPOND)
    • 批准号:
      10369647
    • 项目类别:
    • 资助金额:
      $68.65万
    • 财政年份:
      2018
    • 负责人:
      Benjamin P. Linas
    • 依托单位:
    国内基金
    海外基金
    基于病人旅程地图的HIV/AIDS患者双轨调适策略的混合性研究
    基于潜变量增长混合模型的HIV/AIDS患者症状负担发展轨迹研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      胡亚丽
    • 依托单位:
    基于RET理论模型下的曼陀罗彩绘疗法在老年HIV/AIDS患者中的心理干预研究
    IL-33/NF-κB通路在臭氧暴露致HIV/AIDS患者免疫损伤中的调控机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位: